← Browse by Condition
Medical Condition

chronic hepaititis b infections

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT07342868 Phase 1
Recruiting

Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function

Enrollment
16 pts
Location
United States
Sponsor
Aligos Therapeutics
View Trial →